Pre-applications Clause Samples

Pre-applications. Pre-applications submitted by applicants in response to a Funding Opportunity Announcement will be programmatically reviewed. Applications that meet programmatic criteria will be put in contact with pharmaceutic companies. They may submit a full application for funding, subject to obtaining access to the relevant COMPANY Asset and confidential information from COMPANY and other program requirements. These applicants will be notified to engage with COMPANY to develop and submit a full proposal, which will include documentation of access to the relevant COMPANY Assets and confidential information pursuant to a CRA and related Project Plan, as specified below. No formulated molecule or Good Manufacturing Practice (“GMP”) biopharmaceutical/biologic for the selected COMPANY Assets will be transferred to the applicants unless and until the applicant is awarded the NIH Grant.